Phasebio Pharmaceuticals Inc (PHAS)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
RA Capital Management

Peter Kolchinsky

2,850,000 $9,861 0.14%
2.
Endurant Capital Management

Vishal Saluja And Pham Quang

2,163,518 $7,486 1.95%
3.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

1,553,974 $5,377 +19% 0.11%
4.
Sphera Global Healthcare Fund

Doron Breen And Mori Arkin

750,000 $2,595 0.19%
5. 603,042 $2,087 +89% 0.49%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$4.12 6,000 Director 6,000 2020-12-03 Filing
$3.50 2,000 Director 22,943 2020-11-24 Filing
$3.67 3,000 Director 20,943 2020-11-23 Filing
$3.94 1,000 Officer 7,600 2018-12-13 Filing
$4.46 1,000 Director 1,000 2018-12-17 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.45 3,497 Officer 0 2020-11-23 Filing
$14.00 459 Large Shareholder, Director 415,959 2019-07-01 Filing
$14.00 255 Large Shareholder, Director 52,397 2019-07-01 Filing
$14.00 180 Large Shareholder, Director 162,890 2019-07-01 Filing
$14.00 2,014 Large Shareholder, Director 1,818,638 2019-07-01 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 6,643,704 $22,987 0.51%
2. 4,285,000 $14,826 0.4%
3. 2,318 $8,020 0%
4. 1,607,044 $5,560 0.72%
5. 1,571,586 $5,438 0%
News See All